AIVL0.276%
as of Jul 17
SOLV
GrowthSOLVENTUM CORP.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.
Close · 3M
+15.52%
Held by 2 AI ETFs
QRFT0.040%
as of Jul 8
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals19
Win rate84% (16/19)
Avg buy return+5.40%
AIVL · Weight increase · 2d
SOLV currently trades at $81.31, near 94% of its 52-week high of $86.14, reflecting a 20.3% return over the past 90 days despite a recent 1.3% decline over the last month. This pricing context, combined with SOLV's low P/E of 9.83 and a P/B of 2.72, likely signaled a buying opportunity for AIVL, whose AI system identifies US value stocks based on fundamental and valuation metrics within a pre-filtered value pool. Despite a slight revenue decline of 0.55%, the company's 30.71% return on equity points to strong capital efficiency, a factor the AI would use to distinguish genuine value from potential value traps. The fund's AI appears to have interpreted these metrics favorably during the recent price consolidation, prompting an incremental increase in its SOLV allocation from 0.2611% on July 14th to 0.2752% by July 16th.
weight 0.261% → 0.275% (+0.014 pp)·stock up 6.2% in the 30 days before
Jul 16·entry $81.70·now $79.25Fresh
-3.00%
since Jul 16
AIVL · Weight increase · 2d
SOLV's PER of 9.19 and PBR of 2.72 place it firmly within AIVL's US value-factor universe, complementing its 30.71% return on equity which the AI considers in evaluating fundamental strength. Despite a slight revenue decline of 0.55%, this blend of low valuation metrics and high profitability likely led WisdomTree's AI to identify the company as genuine value, rather than a value trap. The subsequent consecutive weight increase in AIVL, from 0.2595% on July 9 to 0.2635% by July 13, occurred as SOLV's price traded at $76.28, approximately 89% of its 52-week high, after registering a positive 90-day return of 7.8%. This sustained allocation suggests the AI found sufficient intrinsic value to warrant a larger holding, even as the stock gained ground from its one-year lows.
weight 0.260% → 0.264% (+0.004 pp)·stock down 4.3% in the 30 days before
Jul 13·entry $77.42·now $79.25Drifting
+2.36%
since Jul 13
AIVL · Accumulation · 5d
AIVL exhibited a pattern of gradual accumulation in SOLV, with its weight increasing incrementally over several days in late June and early July. This measured upward adjustment, even as SOLV traded near 91% of its 52-week high, aligns with WisdomTree's AI methodology for identifying genuine value within a pre-filtered US value pool. Despite slightly negative revenue growth, the fund's AI likely prioritized SOLV's 30.71% Return on Equity and a P/E ratio of 9.47, signaling a financially efficient company at an attractive valuation. Such steady, deliberate additions reflect the AI distinguishing this healthcare stock as a quality holding rather than a value trap, justifying its growing portfolio allocation.
weight 0.253% → 0.265% (+0.012 pp)·stock up 2.4% in the 30 days before
Jul 2·entry $78.27·now $79.25Fresh
+1.25%
since Jul 2
AIVL · Accumulation · 5d
WisdomTree's AIVL ETF, which employs AI to score names within a pre-filtered US value-factor pool, likely identified Solventum Corp. as a compelling addition to its portfolio of approximately 100 US value stocks. The AI-driven methodology, focusing on fundamentals and valuation metrics, recognized SOLV's low PER of 9.47 and robust ROE of 30.71% as indicative of genuine value rather than a value trap. This financial strength, even with the stock trading at $78.35 and 91% of its 52-week high, prompted a sustained gradual accumulation in AIVL's weight. The consistent increase over several days, despite the fund's periodic rebalancing schedule, suggests the AI continued to favor SOLV based on its internal scoring.
weight 0.261% → 0.269% (+0.008 pp)·stock up 3.3% in the 30 days before
Jul 1·entry $78.35·now $79.25Fresh
+1.15%
since Jul 1
AIVL · Weight increase · 4d
AIVL's strategy employs AI to score US value stocks, focusing on fundamental strength and valuation to distinguish genuine value from potential traps within its portfolio of approximately 100 names. This AI system likely interpreted SOLV's financial profile as increasingly favorable, particularly its 30.71% Return on Equity, which indicates substantial profitability despite a slight revenue contraction. The consecutive weight increases for SOLV, observed over several days in late June, suggest the AI's model has escalated its conviction in the stock during AIVL's periodic rebalancing process. While SOLV currently trades at $78.24, near 91% of its 52-week high, its Price-to-Earnings ratio of 9.14 remains low, aligning with the ETF's value-factor screening criteria.
weight 0.253% → 0.271% (+0.018 pp)·stock up 4.8% in the 30 days before
Jun 26·entry $79.53·now $79.25Fresh
-0.35%
since Jun 26
AIVL · Weight increase · 3d
WisdomTree's AIVL, which uses AI to score and distinguish genuine value within a pre-filtered US value-factor pool, began increasing its allocation to SOLV. The AI’s periodic analysis of fundamentals and valuation metrics likely identified SOLV’s high ROE of 30.71% and a PER of 9.14 as indicators of a quality company, even as the stock’s current price of $79.53 sits at 92% of its 52-week high. This conviction led to the consecutive weight increase observed, moving from 0.2570% on June 23 to 0.2653% on June 25 within the ETF’s portfolio of around 100 US value stocks.
weight 0.253% → 0.265% (+0.013 pp)·stock up 2.2% in the 30 days before
Jun 25·entry $77.92·now $79.25Fresh
+1.71%
since Jun 25
AIVL · Weight increase · 2d
SOLV, currently priced at $75.59, trades at 88% of its 52-week high, having experienced limited upward movement with 30-day, 90-day, and 1-year returns all under 2%. This price positioning, coupled with a PER of 9.14 and PBR of 2.72, would place the Health Care stock firmly within AIVL's pre-filtered US value-factor pool. WisdomTree’s AI, which aims to distinguish genuine value from value traps using fundamentals, likely prioritized SOLV's high 30.71% ROE and strong return on capital, despite a -0.55% revenue growth. The resulting consecutive weight increases for SOLV in AIVL from June 23 onwards indicate the AI’s recent re-evaluation, affirming the stock's inclusion and enhanced weighting based on its valuation and profitability at the $75.59 price level.
weight 0.253% → 0.262% (+0.009 pp)·stock down 1.6% in the 30 days before
Jun 24·entry $75.59·now $79.25Drifting
+4.84%
since Jun 24
AIVL · Weight decrease · 5d
SOLV's PER of 8.95 and PBR of 2.72 initially align with AIVL's strategy of selecting US value-factor stocks, complemented by a 30.71% ROE indicating strong return on capital. However, the negative 0.55% revenue growth likely signaled a potential red flag, prompting AIVL's AI to carefully scrutinize whether SOLV represented genuine value or a value trap within its pre-filtered universe. This reassessment appears to coincide with SOLV's recent price performance, specifically a -9.7% 90-day return and being at 85% of its 52-week high, which began around the time of the initial weight decreases from June 11th. The consistent reductions in AIVL's allocation to SOLV, from 0.2895% on June 10th to 0.2528% by June 22nd, reflect the AI's ongoing adjustment of exposure as it weighs the stock's valuation against its financial fundamentals and recent market performance.
weight 0.290% → 0.253% (-0.037 pp)·stock down 3.4% in the 30 days before
Jun 22·entry $73.56·now $79.25
+7.74%
since Jun 22
AIVL · Weight decrease · 4d
WisdomTree's AIVL, utilizing AI to discern genuine value from potential value traps within its ~100 US value stock universe, has systematically reduced its allocation to SOLV through periodic rebalancing, as evidenced by the consecutive weight decreases over mid-June. This adjustment likely stems from the AI identifying negative revenue growth of -0.55% as a potential long-term drag, despite the company's otherwise low PER of 8.9 and strong ROE. While SOLV recently gained 5.3% over 30 days, the AI appears to prioritize underlying fundamental trends over short-term price movements, especially with the stock trading at 88% of its 52-week high after a flat one-year return. The fund's methodology suggests the AI is signaling caution, potentially perceiving SOLV as less of a deep value opportunity given its current valuation relative to its recent revenue performance.
weight 0.290% → 0.261% (-0.029 pp)·stock up 0.9% in the 30 days before
Jun 18·entry $75.43·now $79.25
+5.06%
since Jun 18
AIVL · Weight decrease · 3d
SOLV’s financial profile presents a P/E of 9.79 and P/B of 2.72, signaling a value-factor candidate, while its 30.71% ROE supports a quality aspect that AIVL’s AI utilizes to discern genuine value from potential traps using fundamentals. However, the reported -0.55% revenue growth introduces a fundamental concern for the AI’s assessment of SOLV's long-term value. Following a recent +5.0% 30-day return that brought the stock to $74.56, approximately 87% of its 52-week high, AIVL initiated a consistent reduction in its SOLV weighting, decreasing from 0.2895% on June 10th to 0.2636% by June 16th. This systematic reduction suggests the AI, operating within its periodic rebalancing schedule, may have perceived SOLV's recent price appreciation, alongside its modest revenue growth, as a shift making it less compelling within its US value-factor universe, potentially reclassifying it closer to a value trap than a core value holding for the fund.
weight 0.289% → 0.264% (-0.026 pp)·stock up 3.1% in the 30 days before
Jun 16·entry $76.56·now $79.25
+3.51%
since Jun 16
AIVL · Weight decrease · 2d
SOLV’s PER of 9.79 and PBR of 2.72 demonstrate characteristics aligning with AIVL’s initial US value-factor screening, while a 30.71% ROE points to strong return on capital, a fundamental metric considered by the AI. However, the AI's mandate within AIVL is to distinguish genuine value from value traps, potentially factoring in the -0.55% revenue growth as a point of caution despite other positive financial signals. This nuanced evaluation by the AI likely contributed to the consecutive weight decrease observed on June 11th and June 12th. Such a reduction in allocation occurred after SOLV posted a 14.0% return over 30 days, bringing its price to 89% of its 52-week high, suggesting the AI found less compelling value at its elevated short-term valuation.
weight 0.289% → 0.274% (-0.016 pp)·stock up 6.0% in the 30 days before
Jun 12·entry $78.87·now $79.25
+0.48%
since Jun 12
AIVL · Weight increase · 2d
weight 0.269% → 0.291% (+0.022 pp)·stock up 19.4% in the 30 days before
Jun 4·entry $82.42·now $79.25Fresh
-3.85%
since Jun 4
AIVL · Accumulation · 5d
Currently at $74.95, SOLV sits at 87% of its 52-week high, exhibiting a 30-day gain of 6.3% following a 90-day decline of 6.7%, presenting a typical scenario for AIVL's AI to evaluate for genuine value. The WisdomTree fund's methodology targets US value stocks, utilizing AI to discern genuine value from value traps based on fundamentals like profitability and valuation metrics. SOLV's PER of 9.06 and PBR of 2.72 align with traditional value screens, while its 30.71% ROE signals significant capital efficiency relative to equity. The AI's gradual accumulation of SOLV, increasing its weight from 0.2551% to 0.2714% over two weeks, indicates its model likely interprets the combination of low valuation ratios and a 30.71% return on equity as a strong signal, differentiating it from a value trap within its rebalancing window despite flat revenue growth.
weight 0.255% → 0.271% (+0.016 pp)·stock up 7.8% in the 30 days before
May 15·entry $74.26·now $79.25Drifting
+6.72%
since May 15
AIVL · Accumulation · 5d
The AI ETF is likely accumulating SOLV due to its extremely attractive valuation, highlighted by a very low PER of 9.0 coupled with an exceptionally high Return on Equity of 30.71%, suggesting a highly profitable company trading at a significant discount despite flat revenue growth. A practical takeaway for retail investors is to prioritize examining core profitability metrics like ROE alongside valuation ratios like PER, as strong fundamental performance can present value opportunities even in companies with minimal or slightly negative top-line growth.
weight 0.250% → 0.268% (+0.018 pp)·stock up 7.7% in the 30 days before
May 14·entry $74.42·now $79.25Drifting
+6.49%
since May 14
AIVL · Accumulation · 6d
The AI ETF is likely accumulating Solventum due to its attractive valuation (low PER of 9.0) combined with exceptionally strong profitability (ROE of 30.71%), indicating an undervalued, efficiently run company despite recent flat revenue. For retail investors, this pattern highlights the importance of analyzing strong profitability metrics like ROE alongside valuation multiples to uncover potentially undervalued assets that might be overlooked solely based on revenue growth figures.
weight 0.246% → 0.268% (+0.022 pp)·stock up 7.8% in the 30 days before
May 13·entry $74.41·now $79.25Drifting
+6.50%
since May 13
AIVL · Accumulation · 7d
The AI likely initiated gradual accumulation in Solventum based on its exceptionally high ROE of 30.71% combined with a low PER of 9.08, suggesting strong profitability and potential undervaluation despite flat revenue growth. This patient strategy indicates the AI is building a position ahead of potential market recognition for SOLV's efficiency. A practical takeaway for retail investors is to investigate companies with robust profitability and attractive valuations, even if recent top-line growth appears subdued, but always conduct independent due diligence.
weight 0.242% → 0.270% (+0.028 pp)·stock up 11.4% in the 30 days before
May 12·entry $75.10·now $79.25Drifting
+5.53%
since May 12
AIVL · Accumulation · 6d
The AI ETF is likely accumulating Solventum due to its exceptionally high Return on Equity (36.74%) alongside a very low Price-to-Earnings ratio (8.25), signaling an identification of an undervalued, highly efficient company despite modest revenue growth. This gradual accumulation suggests a cautious value investing strategy. Retail investors can adopt a similar approach by looking for companies with strong profitability and attractive valuations overlooked by the broader market, considering phased buying to mitigate risk.
weight 0.244% → 0.266% (+0.022 pp)·stock up 12.7% in the 30 days before
May 11·entry $74.12·now $79.25Drifting
+6.92%
since May 11
AIVL · Accumulation · 6d
The AI likely initiated gradual accumulation in SOLV due to its extremely high ROE of 36.74% coupled with a low PER of 8.17, indicating strong profitability and potential undervaluation despite low revenue growth. This measured approach minimizes entry risk while capitalizing on a perceived value opportunity. For retail investors, this highlights the importance of analyzing profitability metrics like ROE in conjunction with valuation ratios, as a strong ROE at a low P/E can signal an efficient, potentially overlooked company that an AI fund would target.
weight 0.244% → 0.265% (+0.020 pp)·stock up 10.9% in the 30 days before
May 8·entry $73.38·now $79.25Drifting
+8.00%
since May 8
AIVL · Accumulation · 5d
The AI ETF likely initiated gradual accumulation in healthcare company SOLV due to its exceptionally high ROE of 36.74% combined with a low PER of 7.97, suggesting strong underlying profitability is potentially undervalued by the market despite its modest revenue growth. The gradual approach helps the AI build a significant position without causing undue market impact or to average into the stock over time. For retail investors, this highlights the importance of analyzing profitability metrics like ROE alongside valuation multiples to identify overlooked opportunities, and the potential benefit of gradually accumulating shares rather than making a single large purchase.
weight 0.244% → 0.259% (+0.015 pp)·stock up 9.8% in the 30 days before
May 7·entry $71.65·now $79.25Chased
+10.61%
since May 7
+11.64%
since May 6
+14.79%
since May 5
+17.65%
since Apr 30
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.